BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company

  May 26, 2026

   · 

  5 min read
• Press Releases

  Merz Therapeutics and Kvvit Enter Exclusive Agreement for INBRIJA® (levodopa inhalation powder) in Mainland China, Hong Kong and Macao

  May 26, 2026

   · 

  4 min read
• Press Releases

  BioPhorum relaunches expanded Host Cell Protein Data Platform to support safer biopharmaceutical development

  The upgraded platform offers a searchable database of over 300 risk-assessed HCPs, automated research scanning, and new flexible pricing options for mid-size drug developers.

  May 26, 2026

   · 

  1 min read
• Press Releases

  HanchorBio Prices IPO at NT$120 Ahead of Innovation Board Listing on May 29

  May 26, 2026

   · 

  3 min read
• Press Releases

  Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke

  May 26, 2026

   · 

  8 min read
• Press Releases

  Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

  May 26, 2026

   · 

  4 min read
• Press Releases

  Editas Medicine Announces Proposed Public Offering - May 26, 2026

  May 26, 2026

   · 

  4 min read
• Press Releases

  Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies New York Healthcare Conference 2026

  May 26, 2026

   · 

  2 min read
• Press Releases

  Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors

  May 26, 2026

   · 

  7 min read
• Press Releases

  Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress

  May 26, 2026

   · 

  5 min read